Metal-peroxide Adduct, Neurodegenerative Diseases, Oxidative Protease Function, Cleavage of Protein Many hypotheses have been developed to explain aging and age-related neurodegenerative disorders; one of the most compelling is the role of oxidative stress to induce changes in protease activity in brains of patients of Alzheimer's disease and prion disease. At the mo ment however, there is no clear answer how protein degradation may be achieved in the brain. We have observed that several metal compounds can degrade proteins in the presence of hydrogen peroxide, and elucidated the reaction scheme based on the new theoretical point for the reactivity of a metal-peroxide adduct with iq1-coordination mode. In this article we would like to point out the importance of a copper(II)-peroxide adduct to promote neurode generative diseases such as prion disease and amyotrophic lateral sclerosis through its oxida tive protease function.
Progressive degeneration of a subset of neurons is the pathologic hallmark of adult-onset neurode generative disorders such as Alzheimer's disease (AD), Parkinson' diseases(PD), and amyotrophic lateral sclerosis (ALS). Growing evidence points to the involvement of oxidative stress in mediating neuronal death in these diseases (Simonian and Coyle, 1996; Mills and Reiner, 1999; Olanow, 1999) .
Alzheimer's disease is characterized by the de position of amyloid plaques in the brain of patients (Mills and Reiner, 1999; Smith et al., 1998) . The amyloid plaques are composed mainly of an insol uble 39-43 residue amyloid ß-proteins (Aß) de rived from a set of larger transmenbrane ß-amyloid precursor proteins (ßAPPs). In the normal state, amyloid precursor protein (APP) is cleaved at a-position ( Fig. 1) , but in the abnormal process ing, this protein is cleaved at both ß-and '/-posi tions, and Aß-protein is secreted into the cell. At present, detailed information on the secretases at a-and y-positions are scarce (Hardy, 1997; Mentlein et al., 1998; Kosik, 1999) .
Prions have become notorious in the past few years as potentially infectious particles implicated in a variety of spongiform encephalopathies, in cluding Creutzfeld-Jacob syndrome, scrapie and "mad-cow disease", and certain serious psychiatric disorders. (Prusiner, 1996 (Prusiner, , 1997 (Prusiner, 1998) . Attached carbohydrate and a glycosyl-phosphatidyl-inositol anchor are indicated. A f ter limited proteolysis, the N H 2 terminus of PrPSc is truncated to form PrP 27-30.
tein(PrPc) achieving an altered prion protein(PrPSc) and also PrP 27-39 (Prusiner, 1998) (Fig. 2) . The gene encoding the prion protein has been sequenced from many mammalian sources; it codes for a protein -250 amino acid residues as illustrated in Figure 2 . The structure of the prion protein has been determined by multidimensional N M R methods; (Glockshuber et al., 1997 ) the re gion (51-91) of the protein contains a group of octarepeats, which have the consensus sequence, Pro-His-Gly3-Try-Gly-Gln (Prince and Gunson, 1998) . Recently it was suggested that copper ions bind to these octarepeats, and that PrPc might act as a 'shuttle' for copper ions destined to bind to enzymes that prevent oxidative damage (Brown et al., 1997 (Brown et al., , 1998 . Truncated PrPSc proteins lacking the copper-binding octarepeats retain their infectivity, suggesting that abnormal cleavage of the prion proteins occurs at this region (see formation of PrP 27-30 in Fig. 2 ). However, it is unclear how the prion protein is degraded. Nature has developed many hydrolytic metalloenzymes, to hydrolyze some of the important molecules of life including proteins, phospholipids, and DNA. (Chin, 1991) For proteins, zinc-contain ing enzymes are well-known, such as carboxypeptidase-A and -B. These enzymes cleave proteins by a hydrolytic mechanism, and are quite different from those described above for cleavage of amy loid and prion proteins. In the latter cases cleavage is due to oxidative stress including an oxygen molecule in a reaction intermediate (Behl, 1999) . In this article, we will focus on the oxidative cleav age of proteins by metal compounds. I. Protein cleavage by metal/oxygen systems There are several reports on the protein degra dation by a metal/oxygen system in vivo and in vitro. Rana and Meares (1991) found that in the presence of ascorbate and hydrogen peroxide, an iron chelate attached to Cys-212 of the enzyme human carbonic anhydrase I quickly cleaves the protein between residues Leu-189 and Asp-190 to produce two discrete fragments (Rana and Meares, 1991; Platis et al., 1993) . In this step, it was confirmed that the transfer of an 180 atom from [180]H 20 2 to the carbonyl group of Leu-189 by mass spectroscopy. They have concluded that gen eration of a highly nucleophilic oxygen species, such as peroxide coordinated to the iron chelate attacks a carbonyl carbon atom nearby (Fig. 3) . However, their conclusion may be wrong, and the experimental result should be considered as fol lows.
According to our recent investigations on the reactivity of the metal-peroxide adducts, both oxy gen atoms of the metal-peroxide adduct with r|!-coordination mode exhibit electrophilicity as shown below Nishida et al., 1997 .
Thus, when the carbon atom of the carboxylic acid approaches to the terminal O atom of 0 2 of the peroxide adduct in the above figure, heterolytic 0-0 cleavage ( 0 2 -* 0 2' + O(neutral)) is pro moted through the electronic interaction between them, and covalent bonding between the carbon atom and the terminal oxygen atom forms associ ated with the cleavage of C-N bond, giving the products (see the figure below). This mechanism explains the incorporation of 180 of the peroxide ion in the product. The importance of electrophi licity of the peroxide adduct has been confirmed by experimental findings Montellano, 1998) .
Many neuropeptides and peptide hormones re quire amidation at the carbonyl terminus for activ ity, and peptidylglycine a-amidating monooxygen ase (PAM) catalyzes the amidation of these diverse physiological regulators (see below) (Prigge et al., 1997) . The amino-terminal domain of the difunctional PAM protein is a peptidylglycine a-hydroxylating monooxygenase (PAM) with two coppers that cy cle through cupric and cuprous oxidation states. In contrast to other dicopper proteins, the coppers in PAM are 11A apart and do not forma binuclear center; in this respect this enzyme is very similar to dopamine ß-hydroxylase (DßH) (Klinman, 1996) The reaction mechanism proposed for the PAM enzymes, is thus similar to that for the dopamine ß-hydroxylase, but the mechanism for the latter enzyme is not established yet. It should be noted that in both cases the formation of a copper(II)-peroxide adduct, Cu(II)-OOH is assumed to be an important reaction intermediate.
As illustrated above, we have been studying the reactivity of the metal-peroxide adducts, and it seems quite likely that the same discussion de scribed for the iron(III)-OOH adduct may eluci date the reaction mechanism in these copper-containing enzymes. We have prepared several copper(II) compounds with the ligands as shown in Fig. 4 , and observed that Cu(bdpg)Cl+ complex exhibits abnormal high activity for hydroxylation of cyclohexane in the presence of hydrogen perox ide, which has been attrib uted to 1) facile peroxide adduct formation through hy drogen bonding with the ligand system(see below), 2) electronic interaction between the peroxide ion and the amide group which enhances the acti vation of the peroxide ion through electron donat ing from the amide group to the peroxide ion.
II. Importance of Cu(II)-OOH and neurodegenerative diseases
In the above section, we showed that Cu(bdpg)Cl+ complex is one of the best models for PAM and DßH enzymes. In addition we have observed that this complex exhibits high activity for cleaving the proteins, such as bovine serum al bumin (BSA) or human carbonic anhydrase I(H-CAI), as shown in Fig. 5 , where the electrophore sis containing a copper(II) complex, protein, and hydrogen peroxide are illustrated . The high activity of the Cu(bdpg)Cl+ com plex relative to Cu(tpa)Cl+ complex is noteworthy, similar to that observed with the hydroxylation of cyclohexane as reported by Okuno et al. (1997) . This suggests that the presence of an amide group near the peroxide ion plays an important role in activating the peroxide ion, which is supported by the fact that Cu(dpgt)Cl+ complex see Fig. 6 ) also shows a high activity for degrading the protein in the presence of hy drogen peroxide. This reasoning may explain the reaction mecha nism for the hydroxylation reaction of cyclohex ane by the Cu(bdpg)Cr/H20 2 system, and PAM and DßH enzymes as well . . H CA I denotes human carbonic anhvdrase I. 0(12) Fig. 6 . Crystal structure of Cu(dpgt)Cl+ C and N denote carbon and nitrogen atoms, respec tively. Small circle attached to these atoms represents hydrogen atom.
Based on above discussions, it seems quite likely that formation of PrP 27-30, which originates from the cleavage of PrPSc near the octarepeat re gion, may be attributed to oxidative protease ac tivity by a copper(II)-OOH species, which is acti vated through interaction with the amide groups coordinated to the copper(II) ion, to cleave the peptide chain nearby (see the figure below).
A similar discussion may be applied to ALS. ALS is a neurodegenerative disease with an inci dence of 1 to 10000. Approximately 1% of the cases of ALS are familial amyotrophic lateral scle rosis (FALS), and in a subset of these cases, muta tion in superoxide dismutase (SOD1), which en codes copper/zinc superoxide dismutase (CuZnSOD), have been demonstrated (Deng et al., 1993; Brown, 1995; W.-Pazos et al., 1996) . It has been hypothesized that the mutations in SOD1 lead to FALS by decreasing the enzymatic activity of CuZnSOD. However, several findings have raised question about this interpretation, (i) the determinations of low CuZnSOD activity were carried out in vitro, in some cases following isola tion of the protein in non physiological conditions, without correlation of in vivo activity, (ii) the FALS-associated SOD1 mutation affect amino acid residues involved in enzyme dimerization or ß-barrel turn, rather than those corresponding to the active sites. Thus, we would like to propose a new consideration on the mutation of SOD1 in FALS.
SOD catalyzes the disproportionation of super oxide ion into peroxide and oxygen molecule, The peroxide ion formed during the reaction is decomposed by glutathione peroxidase, however, it should be noted here that formation of a copper(II)-OOH , a very dangerous compound, is produced. Under normal conditions, the hydrogen peroxide formed may be decomposed rapidly, but with the mutated SOD, this process is prevented peptide chain (Fullerton et al., 1998) and the copper(II)-OOH may give damage to the peptide group nearby This will give more damaged SOD, which is consis tent with the observations in patients of ALS (Rando et al.. 1998; Shaw et al., 1998) . This process also leads to release of a copper(II) ion from SOD, and the released copper(II) ion may become a dangerous ion in cells.
III. Free iron ion and neurodegenerative diseases
Iron is an essential participant in many human metabolic processes, but recent studies on neuro degenerative diseases, have revealed that a free ion, i.e., excess iron ion in the cell is potentially dangerous, and abnormalities in brain iron metab olism have been described for several disorders such as Alzheimer's and Parkinson's disease (McCord, 1996; Gerlach et al., 1994; Double et al., 1998; Loeffer et al., 1995) . We have prepared sev eral model compounds for the "free iron(II) ion" in the cell, and discussed the free iron ion forma tion, the oxygen activation, cell damage, and the cancer stimulation process by the free iron ion (Nishida and Ito, 1995a; 1995b) . As proposed by us, a free iron(III) ion or copper(II) ion may be captured by the chelate containing an amide group, and it is frequently observed that a free Fig. 7 . Crystal structure of Fe7(dpgs)->OCl22+ (Ito et al., 1996) . iron ion in the cell is of a dimeric structure (for example see Fig. 7 ; where a dimeric structure of a binuclear iron(III) compound with a ligand con taining an amide-group is illustrated) (Ito et al., 1996) . We have found that several binuclear iron(III) compounds with an [i-alkoxo bridge, such as Fe2(HPTP)Cl4C104, (chemical structure of the ligand H(HPTP) is illustrated below) can degrade proteins in the presence of hydrogen peroxide, as illustrated in Fig. 8 .
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As is well known, iron(III) and aluminum(III) ions are present in the brain of Alzheimer's dis ease patients (Gerlach et al., 1994) . A large amount of intake of A l(III) ion in brain induces lacking in neurotransmitters and increase in free iron ion (Nishida and Ito, 1995b) . This suggests that cleavage at ß-position in APP may be attrib uted to a free iron ion and hydrogen peroxide. It has been reported that the amyloid protein itself gives damage to the neural cell by decomposing it (Mills and Reiner, 1999) . This may be attributed
